Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-21 · accession 0001415889-23-010180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-22 | 2023-06-21 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | S - Sale+OE | $36.00 | -10.0K | 141.9K | -7% | -$360.0K |
| D | 2023-06-22 | 2023-06-21 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $18.41 | +10.0K | 151.9K | +7% | +$184.1K |
| D | 2023-06-22 | 2023-06-21 | HALO | LaBarre Michael J. | SVP, Chief TECHNICAL Off | M - OptEx | $0.00 | -10.0K | 17.5K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-21 | S | D | 10,000 | $36.00 | 141,911 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-21 | M | A | 10,000 | $18.41 | 151,911 | D | — | — | |
| 3 | Derivative | Option to Purchase Common Stock | 2023-06-21 | M | D | 10,000 | $0.00 | 17,505 | D | $18.41 · — to 2028-02-14 | 10,000 Common Stock | (F2) This option was granted on February 14, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. |